Search by Drug Name or NDC
NDC 31722-0865-25 Linezolid 100 mg/5mL Details
Linezolid 100 mg/5mL
Linezolid is a ORAL GRANULE, FOR SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Camber Pharmaceuticals, Inc.. The primary component is LINEZOLID.
Product Information
| NDC | 31722-0865 |
|---|---|
| Product ID | 31722-865_05657697-e108-9eaf-e063-6294a90a5d97 |
| Associated GPIs | |
| GCN Sequence Number | 045132 |
| GCN Sequence Number Description | linezolid SUSP RECON 100 MG/5ML ORAL |
| HIC3 | W1O |
| HIC3 Description | OXAZOLIDINONE ANTIBIOTICS |
| GCN | 26871 |
| HICL Sequence Number | 021157 |
| HICL Sequence Number Description | LINEZOLID |
| Brand/Generic | Generic |
| Proprietary Name | Linezolid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Linezolid |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | GRANULE, FOR SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 100 |
| Active Ingredient Units | mg/5mL |
| Substance Name | LINEZOLID |
| Labeler Name | Camber Pharmaceuticals, Inc. |
| Pharmaceutical Class | Oxazolidinone Antibacterial [EPC], Oxazolidinones [CS] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA211813 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 31722-0865-25 (31722086525)
| NDC Package Code | 31722-865-25 |
|---|---|
| Billing NDC | 31722086525 |
| Package | 1 BOTTLE, GLASS in 1 CARTON (31722-865-25) / 150 mL in 1 BOTTLE, GLASS |
| Marketing Start Date | 2022-10-31 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |